Latest news with #OrionGroup
Associated Press
12 hours ago
- Business
- Associated Press
Orion Group Holdings Awarded $100 Million in New Contracts
HOUSTON, June 19, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) ('Orion' or the 'Company'), a leading specialty construction company, today announced new Marine and Concrete awards for a total value of approximately $100 million. In addition, Orion's Chief Executive Officer and General Counsel were honored with executive leadership awards. Management Commentary 'We are proud to be recognized with new contract awards that reflect the trust our partners place in us. These achievements are a testament to the strength of our team, our commitment to the highest safety standards, and the progress we are making in expanding our business development pipeline,' said Travis Boone, Chief Executive Officer of Orion Group Holdings, Inc. 'Our strong delivery and consistent execution have enabled us to successfully expand our client relationships and Port Tampa Bay is a good example. For many years, we have been their longstanding partner for maintenance dredging and new construction projects. We are pleased to play a role in their expansion initiatives aimed at enhancing the port's capacity and efficiency.' Boone continued, 'In our Concrete business, we continue to see strong demand, supported by the next phase of a large data center project and several projects in our home state. With our strong reputation and robust pipeline, we are well positioned for continued growth.' New Contracts Orion's Marine business recently secured $67 million in new wins. For Weyerhaeuser Company, Orion Marine was awarded the Longview Export Dock Replacement project. This work involves removing the existing timber Berth A structure and replacing it with a new concrete structure supported by large-diameter steel pipe piles. The project is expected to last 12 months and will begin in the third quarter of 2025. In addition, Orion Marine won two projects with the Port of Tampa Bay. The first award is a 3-year maintenance dredging contract for the Port, estimated to begin work in September 2025. The second contract is for the Port Redwing Berth 301 Wharf project – a crucial project given the rapid population growth in the Tampa Bay region and the increasing demand for construction and bulk materials. Orion Concrete won $33 million in new contract awards, including a data center project in Iowa, the Harris County Sheriff's Office Complex in Houston as a subcontractor for Durotech, Inc., and the foundation of a cold storage facility for U.S. Foods. These projects will commence in the third quarter of 2025 with an estimated duration of one year. In addition, the Company was recently awarded a contract with the City of Ingleside wastewater treatment plant as a subcontractor to Associated Construction Partners. This project is expected to begin in December of 2025 with a duration of 12 months. Executive Leadership Awards Orion's executive leadership team was recently recognized for outstanding achievements. Travis Boone, Orion's Chief Executive Officer, was named a finalist for the EY Entrepreneur of The Year® 2025 Gulf South Award, presented by Ernst & Young LLP. This prestigious recognition honors visionary business leaders who are driving innovation and growth across industries. Chip Earle, Orion's General Counsel, won the Lexology North America Award for in-house general counsel in the construction industry. In association with the Association of Corporate Counsel, Lexology recognizes the outstanding achievements of the world's leading legal practitioners across various practice areas and sectors. About Orion Group Holdings Orion Group Holdings, Inc., a leading specialty construction company serving the infrastructure, industrial and building sectors, provides services both on and off the water in the continental United States, Alaska, Hawaii, Canada and the Caribbean Basin through its marine segment and its concrete segment. The Company's marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including place and finish, site prep, layout, forming, and rebar placement for large commercial, structural and other associated business areas. The Company is headquartered in Houston, Texas with regional offices throughout its operating areas. Forward-Looking Statements The matters discussed in this press release may constitute or include projections or other forward-looking statements within the meaning of the 'safe harbor' provisions of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, of which provisions the Company is availing itself. Certain forward-looking statements can be identified by the use of forward-looking terminology, such as 'believes', 'expects', 'may', 'will', 'could', 'should', 'seeks', 'approximately', 'intends', 'plans', 'estimates', or 'anticipates', or the negative thereof or other comparable terminology, or by discussions of strategy, plans, objectives, intentions, estimates, forecasts, guidance, outlook, assumptions, or goals. In particular, statements regarding our pipeline of opportunities, financial guidance and future operations or results, including those set forth in this press release, and any other statement, express or implied, concerning financial guidance or future operating results or the future generation of or ability to generate revenues, income, net income, gross profit, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, or cash flow, including to service debt or maintain compliance with debt covenants, and including any estimates, guidance, forecasts or assumptions regarding future revenues or revenue growth, are forward-looking statements. Forward-looking statements also include project award announcements, estimated project start dates, ramp-up of contract activity and contract options, which may or may not be awarded in the future. Forward-looking statements involve risks, including those associated with the Company's fixed price contracts that impacts profits, unforeseen productivity delays that may alter the final profitability of the contract, cancellation of the contract by the customer for unforeseen reasons, delays or decreases in funding by the customer, levels and predictability of government funding or other governmental budgetary constraints, and any potential contract options which may or may not be awarded in the future, and are at the sole discretion of award by the customer. Past performance is not necessarily an indicator of future results. Considering these and other uncertainties, the inclusion of forward-looking statements in this press release should not be regarded as a representation by the Company that the Company's plans, estimates, forecasts, goals, intentions, or objectives will be achieved or realized. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company assumes no obligation to update information contained in this press release whether as a result of new developments or otherwise, except as required by law. Please refer to the Company's 2024 Annual Report on Form 10-K, filed on March 5, 2025 which is available on its website at or at the SEC's website at and filings and press releases subsequent to such Annual Report on Form 10-K for additional and more detailed discussion of risk factors that could cause actual results to differ materially from our current expectations, estimates or forecasts. Contact: Margaret Boyce Orion Group Holdings, Inc. [email protected] 312-402-6980 Source: Orion Group Holdings, Inc.
Yahoo
6 days ago
- Business
- Yahoo
Great Lakes Stock Trading at a Discount: Is It Buy Time Now?
Great Lakes Dredge & Dock Corporation's GLDD current valuation is enticing for investors. Currently, the stock is trading below its industry peers with a forward 12-month price-to-earnings (P/E) ratio of 12.43X, as evidenced by the chart below. Moreover, the discounted valuation of GLDD compares favorably with a few of the other market players, including Orion Group Holdings, Inc. ORN, Quanta Services, Inc. PWR and Granite Construction Incorporated GVA. The 12-month P/E ratios of Orion Group, Quanta and Granite Construction are 31.69X, 32.73X and 13.98X, respectively. Image Source: Zacks Investment Research The discounted valuation of GLDD stock, compared with its peers, advocates for an attractive entry point for investors. That said, in the long term, the valuation could move toward a premium, given the strong market fundamentals backing the company's revenue visibility and Texas-based dredging services provider is mainly gaining from large-scale capital and coastal protection projects compared with mainstream maintenance dredging. Thanks to its resilience in offering such services, it enjoys a competitive edge in the market. Moreover, its new build program, proposed in 2020, catalyzes its ability to offer such services efficiently and expand the margins in the process. With such favorable market fundamentals and its in-house capabilities, the company is consistently able to enhance its liquidity position, thus increasing space for strategic long-term investments and shareholder GLDD's shares have soared 34.6% in the past three months, outperforming the Zacks Building Products - Heavy Construction industry, the broader Zacks Construction sector and the S&P 500 index. The detailed price performance can be studied from the chart below. Image Source: Zacks Investment Research Let's delve deeper into understanding the factors driving GLDD's momentum. Great Lakes is significantly benefiting from the robust demand trends for large-scale capital and coastal protection projects. This is because it houses the specifications that are required to offer these services, differing from maintenance dredging, allowing it a competitive advantage over other market players like Orion Group, which mainly offers mainstream dredging services. As of March 31, 2025, GLDD's substantial dredging backlog was $1 billion compared with $879.4 million as of last year's first quarter, with capital and coastal protection projects accounting for 95% of the total dredging main driver for coastal restoration projects is the increased government funding for infrastructure projects, at the state and federal levels, due to the U.S. Army Corps of Engineers or FEMA-backed initiatives backed by the Infrastructure Investment and Jobs Act (IIJA) and the Inflation Reduction Act (IRA). These projects being government-funded, reduce payment failure risks, and with being larger in scale and having longer duration, it also ensures efficient asset utilization. Such characteristics of these projects not only boost the company's revenue visibility but also foster its margin growth. Tailwinds from public infrastructure spending are also aiding other market players like Quanta and Granite Construction. Proposed in 2020, the new build program was approved and rolled out to renew and modernize GLDD's fleet. Through this program, the company mainly aims to stand tall for offering services in coastal restoration and shoreline protection, establishing a resilient business model. As part of this program, the company is currently undergoing construction of Acadia, the first U.S.-flagged Jones Act-compliant subsea rock installation vessel, which is expected to be delivered by the first quarter of 2026. Acadia will be considered for domestic and international offshore wind projects alongside critical subsea infrastructure protection the newest hopper dredge, the Amelia Island (expected delivery in the third quarter of 2025) and the Galveston Island have been designed specifically by GLDD to work efficiently in shallow and narrow waters along the U.S. coastlines, specifically for coastal protection projects such as beach restoration, wetlands improvements and Barrier Island construction. With the program wrapping up by the end of 2025 or the beginning of 2026, the company expects to witness incremental revenue trends and increased free cash flow thereafter. Given the current market uncertainties and an inflationary scenario, maintaining a substantial liquidity position alongside making strategic business investments is a strenuous task. Great Lakes is managing this job just fine by leveraging its increasing top line and almost concluding its investment of March 31, 2025, GLDD had cash and cash equivalents of $11.3 million, up from $10.2 million at 2024-end. Net cash from operating activities, as of the same period, was $60.9 million, up year over year from $38.4 million, attributable to higher earnings in the period and an increase in billings above contract revenues. With no debt maturities until 2029 and liquidity of more than $300 million, the company has a stable liquidity position to function in an uncertain market scenario. GLDD's earnings estimates for 2025 and 2026 have trended upward in the past 60 days by 39.1% to 96 cents per share and 11.8% to 95 cents, respectively. The estimated figure for 2025 reflects 14.3% year-over-year growth, with the same for 2026 indicating a 0.4% inch-down. EPS Trend Image Source: Zacks Investment Research Technical indicators suggest a continued strong performance for Great Lakes. From the graphical representation given below, it can be observed that GLDD stock is riding above both the 50-day simple moving average (SMA) and the 200-day SMA, signaling a bullish trend. The technical strength underscores positive market sentiment and confidence in GLDD's financial health and prospects. 50 & 200-Day Moving Averages Image Source: Zacks Investment Research As discussed above, strong demand trends for large-scale capital and coastal protection projects, backed by a favorable government funding scenario in the US, are the main driving factors for Great Lakes' revenues and margins. The company's competitive edge over its peers for offering these services, thanks to its multi-year new build program, is an added catalyst amid the favorable market optimism regarding GLDD stock is reflected in three of the three recommendations pointing at a "Strong Buy'. Image Source: Zacks Investment Research Thus, based on the above discussion and trends of the technical indicators, this Zacks Rank #1 (Strong Buy) stock is a decent choice to be added to the portfolio for now. You can see the complete list of today's Zacks #1 Rank stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Quanta Services, Inc. (PWR) : Free Stock Analysis Report Orion Group Holdings, Inc. (ORN) : Free Stock Analysis Report Great Lakes Dredge & Dock Corporation (GLDD) : Free Stock Analysis Report Granite Construction Incorporated (GVA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
23-04-2025
- Business
- Yahoo
Orion Group Interim Report January–March 2025
ORION CORPORATION INTERIM REPORT 1–3/2025 23 APRIL 2025 at 12:00 EEST Orion Group Interim Report January–March 2025 January–March 2025 Highlights Net sales totalled EUR 354.6 (January–March 2024: 308.5) million Operating profit was EUR 77.9 (56.0) million Basic earnings per share were EUR 0.44 (0.31) Cash flow from operating activities per share was EUR 0.55 (0.78) Outlook for 2025 remains unchanged: Net sales are estimated to be EUR 1,550 million to EUR 1,650 million. Operating profit is estimated to be EUR 350 million to EUR 450 million. Key figures1–3/25 1–3/24 Change % 1–12/24 Net sales, EUR million 354.6 308.5 +14.9% 1,542.4 EBITDA, EUR million 91.5 68.5 +33.6% 509.4 % of net sales 25.8% 22.2% 33.0% Operating profit, EUR million 77.9 56.0 +39.1% 416.6 % of net sales 22.0% 18.2% 27.0% Profit before taxes, EUR million 76.8 54.9 +39.9% 413.1 % of net sales 21.7% 17.8% 26.8% Profit for the period, EUR million 61.3 43.8 +39.9% 329.9 % of net sales 17.3% 14.2% 21.4% Research and development expenses, EUR million 41.0 36.8 +11.3% 179.6 % of net sales 11.6% 11.9% 11.6% Capital expenditure, EUR million 20.5 13.1 +56.7% 86.1 % of net sales 5.8% 4.2% 5.6% Interest-bearing net liabilities, EUR million 61.8 6.4 > 100 % 121.7 Basic earnings per share, EUR 0.44 0.31 +39.8% 2.35 Cash flow from operating activities per share, EUR 0.55 0.78 -29.7% 2.09 Equity ratio, % 62.9% 48.8% 61.9% Gearing, % 5.8% 0.9% 12.1% Return on capital employed (before taxes), % 23.4% 22.8% 34.9% Return on equity (after taxes), % 23.7% 21.9% 34.8% Average number of personnel during the period 3,928 3,673 +7.0% 3,712President and CEO Liisa Hurme: Strong start for the year "In January–March 2025, our net sales increased by 14.9 percent to EUR 354.6 (308.5) million and operating profit increased by 39.1 percent to EUR 77.9 (56.0) million. The year 2025 has started strongly with almost all business divisions reporting good growth. Nubeqa® continued to drive the growth of the Group and the Innovative Medicines business division. Both royalty income and product sales increased significantly from the comparison period. In addition, Nubeqa®'s product sales grew from the previous quarter and were at an all-time high so far. In Branded Products, all therapy areas grew nicely. Starting from this reporting period, we will split the division's net sales by three therapeutic areas. Each therapy area's strategy is to build business around one key product group. In Respiratory, the key product group is Easyhaler® product portfolio, in CNS entacapone products and in Women's Health Divina® series. Generics and Consumer Health and Animal Health business divisions also continued their growth path as expected in the first quarter of 2025. The decline in Fermion's external net sales from the comparison period is explained by the allocation of capacity more to internal use, as well as by timing of deliveries. Operating profit grew again significantly faster than net sales, which is mostly explained by the growth of Nubeqa® royalties and product sales, but also by the good development of the rest of the business. The growth of Nubeqa® royalties was strong, especially considering the fact that, as usual, the previous quarter's product sales, which were very good at the end of 2024, have been deducted from the royalty. Operating expenses increased but were lower than we anticipated. Sales and marketing expenses were increased by, among other things, investments in the promotion of the Easyhaler® product portfolio, as well as the Japanese sales office established last year. The increase in research and development costs is explained by the progress of clinical development projects and the research portfolio, where the costs of biological medicines, in particular, increase significantly as they approach the clinical development stage. US import tariffs continue to be a hot topic worldwide, and there is a lot of uncertainty around the topic right now. The United States is an important market for Orion, and we will, of course, follow the development of the situation closely. In March, we announced that Orion is establishing a new research & development centre in Cambridge, UK during 2025. With this we aim to accelerate our global growth strategy and the development of innovative medicines. The new centre will focus on the pharmaceutical development of new biological and large-molecule therapies. Orion's own clinical development projects progressed as planned during the early part of the year. In addition, we have added to Orion's list of key clinical development projects a Phase 3 project, in which our partner Tenax develops oral levosimendan for the treatment of pulmonary hypertension in heart failure with preserved ejection fraction. Tenax has announced that it will increase the number of patients in the ongoing study and plans to start during 2025 a second phase III study which is aiming for global registration. With these advances, we felt the time was right to include Tenax Phase III projects with levosimendan in Orion's research pipeline. The original license agreement with Tenax (formerly Phyxius) was signed already in 2013. All in all, the year 2025 has started very well and from here it is good to continue this year forward together with all Orionees and numerous partners.' Outlook for 2025 Net sales are estimated to be EUR 1,550 million to EUR 1,650 million. Operating profit is estimated to be EUR 350 million to EUR 450 million. Webcast and Conference Call A webcast and a conference call for analysts, investors and media representatives will be held on Wednesday, 23 April 2025 at 13.30 EEST. A link to the live webcast is available on Orion's website at A recording of the event will be available on the website later the same day. Conference call can be joined by registering through the following link: Phone numbers and the conference ID to access the conference will be provided after the registration. In case you would like to ask a question during the conference, please dial *5 on your telephone keypad to enter the question queue. Questions can also be presented in writing through the question form of the webcast. Upcoming events Capital Markets Day 2025 Thursday 22 May 2025 Half-Year Financial Report January–June 2025 Friday 18 July 2025 Interim Report January–September 2025 Tuesday 28 October 2025 Espoo, 23 April 2025 Board of Directors of Orion Corporation For additional information about the report: Tuukka Hirvonen, Investor Relations, tel. +358 10 426 2721 or +358 50 966 2721 Publisher: Orion Corporation Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion's A and B shares are listed on Nasdaq Helsinki. Attachment Orion Interim Report Q1 2025Sign in to access your portfolio
Yahoo
11-03-2025
- Business
- Yahoo
Orion Group Financial Statement documents 2024 and Remuneration Report published
ORION CORPORATION STOCK EXCHANGE RELEASE – ANNUAL FINANCIAL REPORT11 MARCH 2025 at 11.15 EET Orion Group Financial Statement documents 2024 and Remuneration Report published Orion Group's Financial Statement documents for 2024 have been published. The documents are available in Finnish and English on the Company's website at and are attached to this release. Financial Statement documents include the company's Financial Statements, the Report by the Board of Directors, the Sustainability Statement (as part of the Report by the Board of Directors), and the Corporate Governance Statement (as part of the Report by the Board of Directors). The Financial Statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements as xHTML file. The primary statements and notes to the Consolidated financial statements have been labelled with XBRL tags. Authorised Public Accountants KPMG Oy Ab has provided an independent auditor's reasonable assurance report on Orion's ESEF Financial Statements in accordance with ISAE 3000 (revised). Orion's Sustainability Statement is prepared according to the European Sustainability Reporting Standards (ESRS) and the Finnish Accounting Act's Chapter 7 on sustainability reporting. Authorised Sustainability Audit Firm KPMG Oy Ab has assured the report at a limited assurance level in accordance with ISAE 3000 (revised). The official Financial Statement documents in accordance with the requirements of the Finnish Accounting Act and the Companies Act, which include the Financial Statements, the Report by the Board of Directors, the Sustainability Statement (as part of the Report by the Board of Directors), the Corporate Governance Statement (as part of the Report by the Board of Directors), the Auditor's Report, and the Assurance Report on the Sustainability Report are available in Finnish at Orion's Remuneration Report 2024 adopted by the Board of Directors has been published as a separate report in Finnish and English on the Company's website at and is attached to this release. Orion Corporation Liisa HurmePresident and CEO Olli HuotariEVP, Corporate Functions Contact person:Tuukka Hirvonen, Investor Relationstel. +358 10 426 2721 Publisher:Orion CorporationCommunicationsOrionintie 1A, FI-02200 Espoo, Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2024 amounted to EUR 1,542 million and the company had about 3,700 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. Attachments 74370029VAHCXDR7B745-2024-12-31-0-en Remuneration report 2024 Orion Financial Statement Documents 2024
